Last updated: January 20, 2023
Sponsor: Haukeland University Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Musculoskeletal Diseases
Ankylosing Spondylitis
Lupus
Treatment
N/AClinical Study ID
NCT04586933
79907
Ages 18-75 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients must be diagnosed with one of the following diagnoses: rheumatoid arthritis,according to the ACR / EULAR 2010 criteria, psoriatic arthritis, according to theCASPAR criteria, axial spondylarthritis, including ankylosing spondylarthritis andnon-radiographic spondylarthritis, according to the ASAS criteria
- Duration of illness ≥0.5 years
- Between 18 and 75 years
- Understand Norwegian
- The patient has given informed consent to participate
- No change in medication the last 12 weeks before inclusion
Exclusion
Exclusion Criteria: Diagnoses / conditions that make it difficult to follow a dietary intervention and / orsupplementation of omega-3s, including:
- Conditions or use of medications where omega-3 is contraindicated
- Pregnancy / lactation
- Allergy to soy or fish
- Severe liver disease
- Severe mental or physical illnesses, such as insulin-requiring diabetes
Study Design
Total Participants: 120
Study Start date:
December 10, 2020
Estimated Completion Date:
June 10, 2025
Study Description
Connect with a study center
Haukeland University Hospital
Bergen, Vestland 5021
NorwayActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.